Days of heat­ed ru­mors cul­mi­nate in a re­port that Ac­celeron is in ad­vanced buy­out talks

Days of frothy ru­mors about pos­si­ble M&A dis­cus­sions at Ac­celeron were capped late Fri­day with a Bloomberg re­port as­sert­ing that the biotech com­pa­ny is in ad­vanced talks for an $11 bil­lion buy­out deal.

Bloomberg was un­able to iden­ti­fy any bid­ders in the deal, but spec­u­la­tion has been run­ning ram­pant that the surg­ing val­ue of Ac­celeron stock had to be the re­sult of leaks around the auc­tion of the com­pa­ny. As of ear­ly Mon­day morn­ing, we’re still await­ing the fi­nal word.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN